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ABSTRACT 
Life expectancy has increased as a result of advancement in medical science. As a result 
the number of elderly in the population is also greater than ever and there is a need to 
tackle their problems. Mild Cognitive Impairment (MCI) is one of the most common 
clinical manifestations affecting the elderly population. This is a transitional stage 
between the cognitive decline of normal ageing and the more serious decline in 
dementia. Timely intervention is awfully important in these cases as they are at a high 
risk of developing dementia. According to Sarangadhara Acharya, Medha (grasping and 
retention power) deteriorates after the fourth decade of life and this may be considered 
as a warning signal for further Smriti (memory) and Buddhi (intellect) deterioration, in 
the successive years. Ayurveda has a major role to play in this arena. The 'Medhya 
Rasayanas' are known to be beneficial to improve the intellectual e.g., Mandukparni 
Swaras, Yashtimadhu Churna with Ksheer, Guduchi Swaras, and Shankhapushpi Kalka. 
Medhya Rasayana drugs are used for prevention and treatment of mental disorders of 
all the age groups. These drugs promote the Intellect (Dhi) Retention power (Dhriti), 
Memory (Smriti). This review discusses about Medhya Rasayanas as a great player for 
prevention and management of age related cognitive decline. 
KEYWORDS: Aging brain, Jara, Mild Cognitive Impairment, Medhya Rasayana. 
INTRODUCTION 
The process of aging begins at birth or 
conception and continues throughout life. This 
process of ageing brings changes which are 
unsolicited, irreversible and inevitable.[1] Current 
trends in demographics coupled with rapid 
urbanization and lifestyle changes have lead to an 
emergence of a host of problems faced by the elderly 
in India. Age related MCI is the cognitive decline of 
thinking, memory and reasoning. Normal ageing and 
Dementia are considered as two opposite ends of a 
continuum and the area of transition between them 
has been recognized as “Mild Cognitive Impairment”. 
The individuals fall in under the category of MCI 
exhibit symptoms, that lie between normal age 
related cognitive Decline from their past level of 
functioning and therefore they do not meet criteria 
for Dementia. 
 India is in a phase of demographic transition. 
According to the state of World Population 2019 
report by the United Nations Population Fund 
(UNFPA) released this year, India’s population in 
2019 stood at 1.36 billion, growing from 942.2 
million in 1994 and it has been projected that by the 
year 2050, the number of elderly people would rise 
to about 324 million. India has acquired the label of 
“an ageing nation” with 7.7% of its population being 
more than 60 year old. As percentage of the older 
people increasing worldwide, their health problem is 
becoming an important public concern. The mental 
health problems of the older adults need to be 
recognized. Among these the neuropsychiatric 
disorders like Dementia, MCI etc. account for 6.6% of 
the total disability.[2] 
 MCI is not mentioned as a disease entity in 
separate chapters of Ayurvedic classics but sign and 
symptoms of the MCI can be understood in terms of 
various Ayurvedic concepts. According to Ayurveda 
Cognition comes under the concept of Gyanotpatti, 
Medha, Buddhi and Smriti. Clinical trials are being 
conducted on MCI worldwide, but an effective 
pharmaceutical management is not present till date. 
Ayurveda believes that Manas and Indriyas are 
Panchbhautika as well as Ahankarika, hence 
Dravyabhoota and Adravyabhoota Chikitsa both 
should be applied in the management of mental 
disorders. Rasayana therapy comes under the 
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purview of both Dravyabhoota and Adravyabhoota 
Chikitsa. Among the Rasayana drugs, Medhya 
Rasayana is the special class of Rasayana acting over 
the neurodegenerative disorder like age related MCI. 
MATERIAL AND METHOD 
 Review study- For this all the verses that 
dealt with age related MCI w.s.r to Smrutibuddhihrasa 
was taken under specific headings. The aetio-
pathogenesis, symptomatologies were taken from 
Ayurveda and modern medical texts, research 
articles, internet sources, Ayurveda data base. 
Disease Review 
 Ageing is fundamentally the outcome of the 
overwhelming of the evolutionary process of the 
body mind system by the evolutionary events 
hallmarked with degenerative changes like 
physiological disturbances of neurotransmitter 
secretions, blunting of dendrites and synapse and 
formation of beta amyloidal plaques warranting 
reparative and rehabilitative care.  
 MCI is considered as prodromal stage of an 
impending Dementia, particularly AD. There is no 
proper cutoff point to separate MCI from Dementia. 
But this is the stage to decide the management’s 
protocols of present and forthcoming consequences. 
Nidana and Samprapti 
The exact cause and mechanism by which age related 
MCI develops is still unknown. But the main 
postulates are: 
1. Genetic causes/gene mutations[3] 
2. Oxidative damage to the nerve cells[4] 
3. Aggregated protein’s in the nerve bodies[5] 
4. Mitochondrial abnormalities[6] 
5. Abnormal neuronal cell death[7] 
6. Impairment in axonal transport[8] 
7. Cytotoxicity[9] 
Diagnostic Criteria for MCI[10] 
1. Memory complaint, preferably qualified by an 
informant 
2. Memory impairment for age 
3. Preserved general Cognitive function 
4. Intact activities of daily living 
5. Not demented  
Ayurvedic Concept of Age related MCI  
Maharshi Charak states 
“Laksanam Manaso Jnanasyabhaobhava Eva Cha” 
(Charak sharir 1/18) 
 Manas is the important factor in the origin of 
Prajnya and hence, all activities (Karmas) which are 
being done. Manas and Indriya are also involved in 
the process of Gyanotpatti. Manas is considered as 
sensory as well as motor entity.[11] However, Mana 
itself is regulated by Vata and in old age 
(Vriddhavastha), Vatavaigunya is already present 
hence functions of Manas is also affected 
physiologically to a great extent. 
 Ageing is a slow and continuous process, 
which affects various bodily tissues at different times. 
There are no two opinions regarding the inclusion of 
declining in Medha (intellect) as part of ageing. In this 
way the process of brain ageing, according to 
Ayurveda, definitely begins in the fourth decade of 
life, which includes neurodegeneration. Therefore, 
neurodegeneration starts in the 4th decade as a part 
of normal phenomena of aging.[12] 
 When the rate of the aging process is 
disproportionate to the age of individual, the 
appearance of signs and symptoms of ageing (Jara) 
before the normal age occur that are mentioned 
under the Aswabhavika aging or Kshaya. It has been 
termed as Akalaja Jara. This type of ageing may be of 
greater intensity and rapidly progressing if no care is 
taken to check it. 
 In Ayurvedic literature, the etiological and 
risk factors for Aswabhavika Kshaya has been clearly 
described by Acharya Charaka and Vagbhata, under 
the heading of Gramya Ahara Vihara and clearly state 
that, regular practicing of these etiological factors 
(Nidanas) lead to different types of diseases related 
with premature aging including Smritibuddhihrasa. It 
is obvious from the above description that the 
majority of etiological factors resulting in premature 
aging because of disproportionate degeneration of 
body tissues with age and Smritibuddhihrasa are 
mainly related with the diet, lifestyle and 
psychological status. They are Vatavriddhikara, Dhatu 
Ojokshayakara, Abhishyandi, Srotovarodhaka and 
Raja and Tamaguna Vriddhikara. Thus, they are 
causing one or more of the following effect in the 
body Srotovarodha, Dhatukshaya, Ojokshaya, Manas 
Dushti, Smritibuddhihrasa, Vatic diseases etc. During 
the old age Vata remains in its increased form which 
may vitiate any time even by the slight indulgence in 
the causative factors of Vata. 
 Neurological disorders are mainly due to 
imbalance in Vata and partial involvement of Pitta 
and Kapha. Vata is responsible for movement of 
impulses through the brain and the nerves which 
control both voluntary and involuntary functions. 
Vata derangements always results in some weakness, 
disturbance, or hypersensitivity of the nervous 
system resulting in, problematic conduction, dryness 
and death of neurons. Likewise, Pitta which is 
responsible for digestion and assimilation plays a 
vital role in either accumulation or clearing out of 
neuro fibrillary tangles and tau proteins. Kapha 
which provides nourishment and sliminess to the 
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synapses helps in proper conduction which is also 
compromised in the pathogenesis.[13] 
 Ojas which is nourished by nutrients is also 
responsible for the compactness of body elements by 
providing adequate nutritional defense against body 
elements. Ojakshaya i.e. inadequate nutritional 
diffuse against body elements is very much 
responsible for aging and age related cognitive 
impairment.[14]  
 There is “Selective alteration” in neurons of 
the brain termed as sites of “Khavaigunya”. This 
alteration is produced due to deviated metabolism 
created by the malfunctioning of Agni 
(Agnivaishamya). Because Agni is responsible for 
each and every catabolic and anabolic activity, this 
leads to down regulation of cholinergic receptors like 
acetyl choline esterase that are prodromal cause of 
cognitive impairment and by accumulation of neuro 
fibrillary tangles and increase the pathology of the 
disease. 
 Dhatukshaya and Margavarodha are the 
cardinal aetiologies for the vitiation of Vata Dosha.[15] 
The accumulation of protein can be understood as 
collection of Aama at the cellular level. Margavarodha 
may be caused of the formation of Aama precipitated 
by Vishamagni which was formed due to Vatadushti. 
Kaayagni is the end process of metabolism occurring 
in tissue level involving bio enzymes which 
determines the proper formation of Saara 
(nourishment) and Kitta (waste) in that level. The 
proper functioning of Vata in cellular level will make 
use of nutrients for building tissues and removing 
wastes from the system. Vikruti of Kaayagni and Vata 
at the level of neurons is the cause of production of 
Aama which leads to AD. This accumulation of waste 
as Aama which can be correlated with protein 
aggregation can disturbs the equilibrium and leads to 
degenerative changes. This degeneration further 
vitiates Vata and it goes on in a vicious circle. The 
possibility of Avarana of Vata should also be 
considered logically as in Pranaavrita Samana there 
will be difficulty in speech, slurring speech and even 
dumbness.[16] If Vyana Vata is occluded by Prana 
Vata, then there will be loss of functions of all the 
senses and there will be loss of memory as well as 
strength.[17] 
Treatment 
 The patient should be given proper 
counseling and mental support i.e. nothing but the 
Satvavajaya Chikitsa as it is the best in management 
of Manovikara (psychological disturbances). This will 
be very helpful to manage the behavioral symptoms 
of patient of MCI. Rasayana therapy including Medhya 
Rasayan and Achara Rasayana must be planned for 
the MCI because it helps us in strengthening the host 
defense mechanism. It is very beautifully says about 
right mental and physical conduct, which when 
followed lead to a disease free life. A regulated 
lifestyle, wholesome diet, appropriate behavior, and 
following ideal code of conduct as quoted in 
Ayurveda are best to prevent and manage the 
Neurodegenerative diseases in general and age 
related MCI in particular.[19] 
 Management of MCI is challenging and 
gratifying despite the absence of cure or a robust 
pharmacologic treatment. Although Donepezil shows 
significant impairment in condition of MCI and 
Alzheimer’s disease but it is accompanied with a lot 
of side effect. 
 Many new scientific studies have been 
conducted showing that the Ayurvedic Rasayana 
therapy is very useful in the prevention of prognosis 
of cognitive impairments and other neuro-
degenerative disorders. Among the Rasayana drugs, 
Medhyarasayana are the special class of drugs 
described for prevention and management of 
smritibuddhihrasa and simultaneously managing the 
consequences of aging. Charkokta Medhyarasayana 
drugs mentioned are Mandookaparni, Guduchi, 
Yastimadhu, and Shankapushpi may have 
pharmacological action similar to the nootropic 
agents.[20] It may have effect on cerebral circulation 
and may enhance oxygen consumption and glucose 
utilization by the brain cells. Potentially it may be 
useful in cases of degenerative brain disorders. Early 
detection of the problem and early starting of the 
appropriate Rasayanas is required to prevent the 
progress of the condition. Medhya drugs are useful in 
the prevention and management of cognitive 
impairments and effective in improving not only the 
quality of life of the patient, but also the care 
givers/family members in broader sense. Thus in 
conclusion, the control of aging and prevention of 
cognitive impairments is possible by Rasayana by 
which some or the other way improve the life 
expectancy. 
Utility of Medhya rasayana[21]  
Medhya Rasayana has a specific purpose of 
benefitting Medha in particular and they do not have 
broad spectrum of action like other Rasayanas. As per 
Acharya Susruta, the benefits derived from Medhya 
Rasayana and their applied aspects are enlisted 
below.  
1. Shruta Nigadi (Power of retention of scriptures)  
2. Smrutiman (Endowed with good memory)  
3. Medhavi (Becomes genius)  
4. Grantham Ipsitam utpadayati (Develops 
enthusiasm to read the scriptures)  
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5. Nastam cha Pradurbhavati (Power to recollect 
the forgotten)  
6. Dvirucchaaritam shatamapi avadharayati 
(Capable of retaining 100 words spoken only 
twice)  
7. Moorthimatisccha enam vagdevyanupravishyati 
(Goddess of speech enters one’s body)  
8. Sarvaischa enam shrutayaupatishtanti (All the 
srutis remain within)  
9. Shruta dharaya panchavarsha shatayur bhavati 
(Power of remembering the scriptures and a life 
of 500 years)  
10. Shrotram vivriyate (Endowed with good hearing 
capacity)  
11. Dvirabhyasat smrutiman bhavati (Endowed with 
good memory)  
12. Trirabhyasat shrutamadatte (Retains the 
scriptures in one’s mind)  
13. Sarvam tarati kilvisham (Gets rid of all blemishes)  
Probable mode of action of Medhya Rasayana 
The Medhya effect of Rasayana can be 
considered as Prabhava janya (unthinkable and 
unimaginable). This attribution holds good since the 
action of Medhya dravya cannot be related to a 
particular quality of the drug. Maintaining of normal 
functioning of Sadhaka pitta and Tarpaka kapha is 
the desired action of any Medhya drug. Medhya drugs 
also act on Manasika bhavas (faculties of mind) there 
by relieving anxiety, stress etc. They are having 
Mastishka balya (nourishing brain) property. It is 
very difficult to conclude the mode of action of 
Medhya Rasayanas as the mechanism of Medha is 
very complex one and the properties of Medhya 
Rasayana are also not uniform.  
Mandukaparni (Centella asiatica Linn.)  
1. Major constituents of it are saponins, 
medacoside, asiaticoside, medacassoside and 
asiatic acid, a new triterpenic acid.[22] 
2. They act on behavior besides being neuro-
protectives and brain growth promoters. 
Dendritic arborization is supposed to be the 
neuronal basis for improved learning and 
memory.[23] 
3. Anti-seizure activity may result from direct or 
indirect modulation of ATPase activity. Centella 
asiatica Linn. inhibits the memory impairment 
induced by scopolamine through the inhibition of 
AChE.[24] 
4. Methanol extract of Centella asiatica Linn. 
showed highest free radical scavenging activity 
that can be attributed to the presence of 
polyphenols and flavonoids as this fraction 
contains maximum amount of these secondary 
metabolites (0.07mg/ml). These two namely poly 
phenols and flavonoids are responsible for potent 
anti-oxidant activity and terminate free 
radicals.[25]  
5. Centella asiatica Linn. extract selectively 
decreases amyloid beta levels in hippocampus of 
Alzheimer's disease animal model.[26] 
6. Centella asiatica Linn. accelerates nerve 
regeneration upon oral administration and 
contains multiple active fractions increasing 
neurite elongation in-vitro.[27] 
Yasthimadhu (Glycyrrhiza glabra Linn.)  
1. The roots and rhizomes of G. glabra have been 
studied with respect to spatial learning and 
passive avoidance, preliminary free radical 
scavenging, cerebral ischemia and antioxidant 
capacity towards LDL oxidation.[28] 
2. Glycyrrhiza glabra Linn. aqueous extract 
markedly improves anti-hypoxic effects induced 
by sodium nitrite in rats and this effect may be 
mediated by its antioxidant properties.[29] 
3. The roots and rhizomes of Glycyrrhiza glabra 
Linn. is an efficient brain tonic; it increases the 
circulation into the CNS system and balances the 
sugar levels in the blood.[30]  
4. Liquorice has significant action on memory 
enhancing activity in dementia. It significantly 
improved learning and memory on scopolamine 
induced dementia.[31] 
Guduchi (Tinospora cordifolia (Willd) Miers.)  
1. Its root is known for its anti-stress, anti-leprotic 
and anti-malarial activities.[32] 
2. Chemical constituents’ classes are alkaloids, 
diterpenoid lactones, glycosides, steroids, sesqui 
terpenoids, phenolics, aliphatic compounds and 
polysaccharides.[33] 
3. Neuro protective and ameliorative properties are 
due to their antioxidant and trace element 
contents.[34] 
4. Tinospora cordifolia (Willd) Miers. is known to be 
a rich source of trace elements (Zinc and Copper) 
which act as antioxidants and protects cells from 
the damaging effects of oxygen radicals generated 
during immune activation.[35] 
5. It increases the blood profile and has lead 
scavenging activity.[36]  
6. Tinospora cordifolia (Willd) Miers. has been 
claimed to possess learning and memory 
enhancing and antioxidant activities.[37] 
7. Tinospora cordifolia (Willd) Miers. enhanced the 
cognition in normal and cognition deficit animals 
in behavioural test Hebb William maze and the 
passive avoidance task. Mechanism of cognitive 
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enhancement is by immune stimulation and 
increasing the synthesis of acetylcholine, this 
supplementation of choline enhances the 
cognition.[38]  
8. Myriad actions of Guduchi may be attributed to its 
antioxidant and immune modulatory 
properties.[39] 
Shankhapushpi (Convolvulus pleuricaulis Chois.)  
1. Important chemical principles are microphyllic 
acid, shankhapushpin, kaempferol kaempferol-3-
glucoside, 3, 4 dihydroxycinnamic acid 
andsitosterols. Neuro-protectve and intellect 
promoting activity is implicated to the free 
radical scavenging and antioxidant properties. [40] 
2. BR-16A (Mentat) a poly-herbal combination 
containing Shankhapushpi significantly reversed 
the social isolation stress-induced prolongation 
of onset and decrease in pento barbitone induced 
sleep, increased total motor activity and stress 
induced anti nociception in experimental 
model.[41] 
3. Ayushman-8 (containing Shankhpushpi, Brahmi 
and Vacha) reported to be effective on Manasa 
mandata (mental retardation).[42] 
4. Shankhapushpi compound containing 
Shankhapushpi, Sarpagandha, and Gokshura in 
equal quantities are studied to be effective in 
Chittodvega (anxiety disorders).[43] 
5. Shankhapushpi is effective in relieving signs and 
symptoms of Chittodvega (anxiety disorders).[44] 
6. Herbalists believe that Shankhpushpi calms the 
nerves by regulating the body's production of the 
stress hormones, adrenaline and cortisol.[45] 
7. Few investigations report that Shankhpushpi has 
potent depressive action in mice.[46]  
8. Convolvulus pleuricaulis Chois. whole plant 
extract, shows the highest inhibitory activity 
against Helicobacter muridarum.[47] 
9. Convolvulus pleuricaulis Chois. aqueous extract 
possesses neuro protective potential, thus 
validating its use in alleviating toxic effects of 
scopolamine.[48] 
DISCUSSION 
 Regarding administration of Medhya 
rasayana Acharya Charaka suggests taking it as 
Vatatapikarasayana, as the description is found in 
‘Kara prachiteeya rasayana pada’ which mainly deals 
with Vatatapika rasayana. Whereas as per Acharya 
Susruta almost all Medhya Rasayanas mentioned are 
to be administered in Kutipraveshika vidhi. So both 
the methods of administration can be considered in 
the context of Medhya Rasayana. Early morning 
before food is preferred as the ideal time for the 
administration of Medhya Rasayana. In Yoga 
Ratnakara, ‘Prabhata’ is the word used for the time of 
administration for the four Medhya formulations. 
Medhya drugs are mainly Madhura and Sheeta 
dravyas, but there are many Medhya drugs which do 
not possess these qualities. It is observed that main 
Medhya Rasayanas (Mandukaparni, Yasthimadhu, 
Guduchi and Sankhapushpi) are Madhura vipaki 
dravyas. Majority of them are Seeta veerya dravyas. 
Medha is the karma given to Prakrita pitta. This can 
be related to orientation and grasping power. 
Guduchi, being Madhura vipaka and Ushna virya can 
help in enhancing grasping power as its constitution 
is ideal for Karma of Pitta, especially Sadhaka pitta. It 
can stimulate neuronal functions due to the Pachana 
karma. The Madhura vipaki and Seeta virya dravyas 
can help the function of Tarpaka kapha to go on 
smoothly owing to its constitution that is favourable 
for Kapha karma. Dhruti i.e., Dharana shakthi, 
memory retention capacity can occur in the presence 
of only Seeta virya. Pharmacological studies reveal 
that Mandukaparni has neuroprotective, brain 
growth promoter, anti seizure activities and free 
radical scavenger (antioxidant) properties and is 
helpful in subsiding neurodegenerative changes that 
occur with Alzheimer’s disease and also accelerates 
repair of damaged neurons; It has been found that 
Yasthimadhu is an anti-oxidant, memory enhancer 
and improves antihypoxic effects; Guduchi has got 
neuroprotective, antioxidant, memory enhancing, 
anti-stress, antileprotic and antimalarial properties; 
It is observed that Shankhapushpi has got antistress, 
neuroprotective and antioxidant properties. 
CONCLUSION  
 Promotion of mental health is the need of the 
hour. Ayurveda a holistic science provides solutions 
for memory related disorders in a fruitful way. 
System of Ayurveda with its longest clinical 
experiences can do a lot for preventing and 
management of MCI and other neurodegenerative 
disorders. Ayurveda treatments like Medhya 
Rasayana, Achara Rasayana, Satvavajaya Chikitsa etc. 
can effectively reduce the progression of disease and 
provide a better quality of life to patients of MCI. In 
the present scenario Medhya Rasayana drugs of 
Ayurveda can be used to obtain effective results in 
memory related disorders. Hence attempt has been 
made to think logically in the aspect of memory 
promotion in a view to seek greener pastures. 
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